Pricing Log in Create free account

Chemomab Therapeutics Ltd. Sponsored ADR (CMMB) vs IN8bio, Inc. (INAB)

Chemomab Therapeutics Ltd. Sponsored ADR and IN8bio, Inc. are both Biotechnology companies. Chemomab Therapeutics Ltd. Sponsored ADR is the larger, with a market value of $9.1M against $8.2M — 1.1× the size. Across the 9 metrics below, Chemomab Therapeutics Ltd. Sponsored ADR leads on 5 and IN8bio, Inc. on 4.

Valuation

Metric CMMB INAB Biotechnology median
P/E n/m n/m 10.26
P/S n/m n/m 9.18
P/B 1.17 0.89 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m 0.08 0.65
EV/Sales n/m n/m 8.98
Earnings yield (62.99%) (255.95%) (34.89%)
Free cash flow yield (358.23%) (89.47%) (24.52%)

Profitability

Metric CMMB INAB Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (82.17%) (111.11%) (50.12%)
Return on assets (70.70%) (90.80%) (45.60%)
Return on invested capital (247.40%) (2,948.56%) 0.00%

Growth

Metric CMMB INAB Biotechnology median
Revenue growth (TTM) — — 6.26%
EPS growth (last fiscal year) 53.65% 74.06% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CMMB INAB Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 6.41 8.21 4.89
Net debt to EBITDA 1.09 1.56 1.01

Dividend

Metric CMMB INAB Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CMMB INAB Biotechnology median
Market cap 9.06m 8.19m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack